Skip to main content

Concert Pharmaceuticals, Inc.

CNCEDelisted Mar 6, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001367920

Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Concert Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Concert Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Concert Pharmaceuticals, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hutt Peter BartonDirector0Mar 6, 20230
Aldrich RichardDirector0IndirectMar 6, 20230
Jaeger Wilfred EDirector0Mar 6, 20230
Cassella James VChief Development Officer0Mar 6, 20230
Auchincloss Thomas GDirector0Mar 6, 20230
van Heek ChristiDirector0Mar 6, 20230
Stuart NancyChief Operating Officer0Mar 6, 20230
Tung Roger DChief Executive Officer0IndirectMar 6, 20230
Becker Marc A.Chief Financial Officer0Mar 6, 20230
Munsie Jeffrey AChief Legal Officer0Mar 6, 20230
Hoeiland JesperDirector0Mar 6, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 16, 2023 (view filing)Feb 151 dayStuart NancyChief Operating OfficerSSale−6.05K$8.33−$50.4K−2.3%262.6K after
Feb 16, 2023 (view filing)Feb 151 dayMunsie Jeffrey AChief Legal OfficerSSale−3.76K$8.34−$31.4K−4.1%88.0K after
Feb 16, 2023 (view filing)Feb 151 dayCassella James VChief Development OfficerSSale−3.76K$8.34−$31.4K−2.1%173.1K after
Feb 16, 2023 (view filing)Feb 151 dayBecker Marc A.Chief Financial OfficerSSale−3.76K$8.33−$31.3K−2.9%123.9K after
Jan 31, 2023 (view filing)Jan 301 dayStuart NancyChief Operating OfficerSSale−13.2K$8.35−$110.2K−4.7%268.6K after
Jan 31, 2023 (view filing)Jan 301 dayMunsie Jeffrey AChief Legal OfficerSSale−8.49K$8.35−$70.9K−8.5%91.8K after
Jan 31, 2023 (view filing)Jan 301 dayCassella James VChief Development OfficerSSale−10.1K$8.35−$84.4K−5.4%176.8K after
Jan 31, 2023 (view filing)Jan 301 dayBecker Marc A.Chief Financial OfficerSSale−8.49K$8.35−$70.9K−6.2%127.6K after
Jan 9, 2023 (view filing)Jan 63 daysTung Roger DChief Executive OfficerSSale−9.24K$7.24−$66.9K−0.9%971.0K after
Jan 9, 2023 (view filing)Jan 63 daysStuart NancyChief Operating OfficerSSale−2.89K$7.25−$21.0K−1.0%281.8K after
Jan 9, 2023 (view filing)Jan 63 daysMunsie Jeffrey AChief Legal OfficerSSale−2.89K$7.25−$21.0K−2.8%100.3K after
Jan 9, 2023 (view filing)Jan 63 daysCassella James VChief Development OfficerSSale−2.89K$7.25−$21.0K−1.5%186.9K after
Jan 9, 2023 (view filing)Jan 63 daysBecker Marc A.Chief Financial OfficerSSale−2.89K$7.25−$21.0K−2.1%136.1K after
Oct 18, 2022 (view filing)Oct 144 daysHutt Peter BartonDirectorSSale−3.54K$6.09−$21.6K−10.7%29.5K after
Jun 6, 2022 (view filing)Jun 6Same dayvan Heek ChristiDirectorPPurchase+10.5K$4.75+$50.0K+69.6%25.7K after
Jun 6, 2022 (view filing)Jun 6Same dayAuchincloss Thomas GDirectorPPurchase+6.00K$4.75+$28.5K+51.6%17.6K after
Jun 6, 2022 (view filing)Jun 6Same dayAldrich RichardDirectorPPurchase+210.5K$4.75+$1.00MNew position210.5K after
Feb 16, 2022 (view filing)Feb 151 dayTung Roger DChief Executive OfficerSSale−13.5K$3.09−$41.7K−1.4%980.3K after
Feb 16, 2022 (view filing)Feb 142 daysStuart NancyChief Operating OfficerSSale−6.05K$3.08−$18.6K−2.1%284.7K after
Feb 16, 2022 (view filing)Feb 142 daysMunsie Jeffrey AChief Legal OfficerSSale−3.76K$3.09−$11.6K−3.5%103.2K after
Feb 16, 2022 (view filing)Feb 142 daysCassella James VChief Development OfficerSSale−3.76K$3.09−$11.6K−1.9%189.8K after
Feb 16, 2022 (view filing)Feb 142 daysBecker Marc A.Chief Financial OfficerSSale−3.76K$3.08−$11.6K−2.6%139.0K after
Jan 7, 2022 (view filing)Jan 61 dayTung Roger DChief Executive OfficerSSale−9.24K$3.09−$28.6K−1.2%784.8K after
Jan 7, 2022 (view filing)Jan 52 daysStuart NancyChief Operating OfficerSSale−2.89K$3.19−$9.23K−1.7%170.4K after
Jan 7, 2022 (view filing)Jan 52 daysMunsie Jeffrey AChief Legal OfficerSSale−2.89K$3.20−$9.26K−6.3%43.3K after
Jan 7, 2022 (view filing)Jan 52 daysCassella James VChief Development OfficerSSale−2.89K$3.19−$9.23K−3.4%83.1K after
Jan 7, 2022 (view filing)Jan 52 daysBecker Marc A.Chief Financial OfficerSSale−2.89K$3.20−$9.26K−4.5%61.2K after
Dec 15, 2021 (view filing)Dec 132 daysTung Roger DChief Executive OfficerSSale−6.70K$3.62−$24.3K−0.8%808.6K after
Aug 17, 2021 (view filing)Aug 161 dayCassella James VChief Development OfficerSSale−8.09K$3.28−$26.5K−8.6%86.0K after
Aug 17, 2021 (view filing)Aug 161 dayBecker Marc A.Chief Financial OfficerSSale−7.30K$3.28−$24.0K−10.2%64.1K after